GPR109A/HCAR2 plays a significant role in regulating the blood–retinal barrier’s integrity and has therapeutic potential toward preventing and treating retinal diseases such as diabetic retinopathy, in which the compromised barrier function is of paramount importance [74]. The gene discussed is HCAR2; the disease is Abnormal retinal morphology.